Skip to main content
. 2022 Dec 14;13:962987. doi: 10.3389/fneur.2022.962987

Table 3.

Baseline, clinical, and angiographic results in subgroup analysis.

ICAD group Non-ICAD group P
(n = 58) (n = 174)
Age (year), median (IQR) 63.6 (53.3, 69.9) 67.4 (59.5, 72.5) 0.021
Male sex, no. (%) 43 (74.14%) 107 (61.49%) 0.081
NIHSS, median (IQR) 15.0 (11.0, 19.0) 18.0 (14.0, 21.0) 0.002
ASPECTS, median (IQR) 8.0 (8.0, 10.0) 8.0 (7.0, 10.0) 0.521
Time from stroke onset to groin puncture (min), median (IQR) 282.6 (214.8, 334.8) 255 (195, 310.2) 0.024
Bridging intravenous fibrinolysis, no. (%) 26 (44.83%) 66 (37.93%) 0.352
Cerebral arterial occlusion, no. (%)§
  ICA 19 (32.76%) 68 (39.54%) 0.022
  MCA M1 segment 37 (63.79%) 80 (46.51%)
  MCA M2 segment 2 (3.45%) 24 (13.95%)
Use of balloon guide catheter 1 (1.72%) 30 (17.24%) 0.003
Rescue measures, no. (%)
  Single balloon angioplasty 13 (22.41%) 0 (0.00%)
  Single stenting 11 (18.97%) 5 (2.87%) <0.001
  Balloon and stent angioplasty 22 (37.93%) 0 (0.00%)
Final successful reperfusion, n. (%)a 55 (94.83%) 156 (90.70%) 0.476
Symptomatic Intracranial hemorrhage within 36 h, no. (%)b 4 (6.90%) 19 (11.18%) 0.350
Time from groin puncture to successful reperfusion, min, median (IQR) 67.2 (46.2, 90.0) 52.8 (35.4, 76.8) 0.004
mRS 0–2 at 90 days, no. (%)c 37 (64.91%) 95 (55.88%) 0.232
Death within 90 days, no. (%) 4 (6.90%) 30 (17.24%) 0.054
a

DSA imaging data were lost for two patient in the non-ICAD group, and in sub-analysis, the lost mTICI score wasn't filled with the worst value.

b

Data on the symptomatic intracranial hemorrhage within 36 h were missing for four patients in the Non-ICAD group.

c

Data on mRS at 90 days were missing for one patient in the ICAD group and four patients in the non-ICAD group.

Bold values of P indicate a statistically significant difference.